Sign in Pull a receipt

NSTM

NovelStem International Corp.

Healthcare · Diagnostics & Research

$214.63 sample

+1.04 (+0.49%) 1D

Market cap

$574.3B

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$214.63 +8.83% 3M daily closessample

216.12195.18

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 22INSInsider buy: 10% owner
Oct 19INSInsider sell: 10% owner
Oct 13INSInsider sell: 10% owner
Oct 08INSInsider sell: EVP, Operations
Oct 01INSInsider sell: Chief Financial Officer
Sep 28INSInsider sell: Director
Sep 23INSInsider sell: Chief Executive Officer
Sep 16INSInsider buy: EVP, Operations

Sign up to see the real NSTM record →

Company facts

SEC EDGAR registration

Name: NovelStem International Corp.
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: -24sample, -100 to +100
Reporting currency: USD

Who is positioning in NSTM

sample

Insiders: 25 insider transactions over 90 days, net selling, $373.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 15 funds hold $9.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.6B +14.5% y/y

Q4 2024Q3 2026

Inventory$9.9B +18.8% y/y

Q4 2024Q3 2026

Accounts receivable$7.6B +11.5% y/y

Q4 2024Q3 2026

Total debt$19.0B +10.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $414.1B +9.0% 3M
Sample peer B: $568.5B -6.7% 3M
Sample peer C: $351.5B -1.9% 3M
Sample peer D: $74.2B -3.7% 3M
Sample peer E: $130.7B -11.1% 3M